Reneo Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Reneo Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Reneo Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 33.4M shares, a 1.12% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 33.4M -380K -1.12% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 33.4M +8.31M +33.1% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 33.4M +8.72M +35.3% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 33.9M +9.34M +38.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 33.8M +9.32M +38.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 25.1M +649K +2.65% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 24.7M +244K +1% Dec 31, 2022 10-K 2024-03-28
Q3 2022 24.5M +122K +0.5% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 24.5M +191K +0.79% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 24.5M +22.3M +1052% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 24.5M +22.4M +1091% Dec 31, 2021 10-K 2023-03-27
Q3 2021 24.4M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 24.3M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 2.12M Mar 31, 2021 10-Q 2021-05-20
Q4 2020 2.05M Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.